| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |